The obesity paradox in pulmonary arterial hypertension: the Scottish perspective

Luke Lawson McLean, Katherine Pellino, Melanie Brewis, Andrew Peacock, Martin Johnson, Alistair Colin Church

Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019
Journal Issue: October
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Luke Lawson McLean, Katherine Pellino, Melanie Brewis, Andrew Peacock, Martin Johnson, Alistair Colin Church. The obesity paradox in pulmonary arterial hypertension: the Scottish perspective. ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is there an obesity paradox in pulmonary arterial hypertension?
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


REVEAL: a contemporary US pulmonary arterial hypertension registry
Source: Eur Respir Rev 2012; 21: 8-18
Year: 2012


Pulmonary arterial hypertension among elderly patients: an emerging problem?
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016


The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Source: Eur Respir Rev 2013; 22: 543-551
Year: 2013



The challenges in paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 498-504
Year: 2014



The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005

Trends in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 7-12
Year: 2009

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017
Year: 2017



COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020



Pulmonary hypertension and obesity
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008

A paradigm shift in pulmonary arterial hypertension management
Source: Eur Respir Rev 2013; 22: 423-426
Year: 2013


Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Autoimmunity and pulmonary arterial hypertension: The role of leptin
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Contemporary issues in pulmonary hypertension
Source: Eur Respir Rev 2010 19: 266-271
Year: 2010


When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Sex matters in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 553-554
Year: 2014


Challenging the concept of adding more drugs in pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017
Year: 2017



Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011